Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,049,020
-
Share change
-
-338,248
-
Total reported value
-
$134,862,274
-
Put/Call ratio
-
0%
-
Price per share
-
$3.85
-
Number of holders
-
90
-
Value change
-
-$2,135,512
-
Number of buys
-
36
-
Number of sells
-
64
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q4 2021
As of 31 Dec 2021,
AVROBIO INC - COM (AVRO) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,049,020 shares.
The largest 10 holders included
JPMORGAN CHASE & CO, Atlas Venture Life Science Advisors, LLC, BlackRock Inc., FEDERATED HERMES, INC., GMT CAPITAL CORP, VANGUARD GROUP INC, Camber Capital Management LP, GOLDMAN SACHS GROUP INC, Deep Track Capital, LP, and Aisling Capital Management LP.
This page lists
90
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.